Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1982 2
1983 2
1984 4
1985 8
1986 5
1987 6
1989 3
1990 9
1991 4
1992 6
1993 11
1994 17
1995 16
1996 17
1997 8
1998 15
1999 9
2000 13
2001 8
2002 17
2003 11
2004 15
2005 16
2006 15
2007 23
2008 34
2009 43
2010 56
2011 45
2012 42
2013 45
2014 55
2015 58
2016 55
2017 45
2018 58
2019 43
2020 39
2021 23
Text availability
Article attribute
Article type
Publication date

Search Results

801 results
Results by year
Filters applied: . Clear all
Page 1
Renal cell carcinoma.
Rini BI, Campbell SC, Escudier B. Rini BI, et al. Lancet. 2009 Mar 28;373(9669):1119-32. doi: 10.1016/S0140-6736(09)60229-4. Epub 2009 Mar 5. Lancet. 2009. PMID: 19269025 Free article. Review.
Sorafenib: key lessons from over 10 years of experience.
Escudier B, Worden F, Kudo M. Escudier B, et al. Expert Rev Anticancer Ther. 2019 Feb;19(2):177-189. doi: 10.1080/14737140.2019.1559058. Epub 2018 Dec 21. Expert Rev Anticancer Ther. 2019. PMID: 30575405 Review.
Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity.
Escudier M, Cautela J, Malissen N, Ancedy Y, Orabona M, Pinto J, Monestier S, Grob JJ, Scemama U, Jacquier A, Lalevee N, Barraud J, Peyrol M, Laine M, Bonello L, Paganelli F, Cohen A, Barlesi F, Ederhy S, Thuny F. Escudier M, et al. Circulation. 2017 Nov 21;136(21):2085-2087. doi: 10.1161/CIRCULATIONAHA.117.030571. Circulation. 2017. PMID: 29158217 No abstract available.
Sorafenib in advanced clear-cell renal-cell carcinoma.
Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Freeman S, Schwartz B, Shan M, Simantov R, Bukowski RM; TARGET Study Group. Escudier B, et al. N Engl J Med. 2007 Jan 11;356(2):125-34. doi: 10.1056/NEJMoa060655. N Engl J Med. 2007. PMID: 17215530 Free article. Clinical Trial.
Cabozantinib, a New Standard of Care for Patients With Advanced Renal Cell Carcinoma and Bone Metastases? Subgroup Analysis of the METEOR Trial.
Escudier B, Powles T, Motzer RJ, Olencki T, Arén Frontera O, Oudard S, Rolland F, Tomczak P, Castellano D, Appleman LJ, Drabkin H, Vaena D, Milwee S, Youkstetter J, Lougheed JC, Bracarda S, Choueiri TK. Escudier B, et al. J Clin Oncol. 2018 Mar 10;36(8):765-772. doi: 10.1200/JCO.2017.74.7352. Epub 2018 Jan 8. J Clin Oncol. 2018. PMID: 29309249 Free PMC article.
801 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page